Literature DB >> 30051610

Lingual lymph nodes in patients with squamous cell carcinoma of the tongue and the floor of the mouth.

Jun Jia1,2, Meng-Qi Jia1, Hai-Xiao Zou3.   

Abstract

BACKGROUND: The treatment failure for oral squamous cell carcinoma (SCC) frequently takes the form of local and regional recurrences. We investigated the role of lingual lymph nodes (LLNs) in the recurrence of SCC of the tongue and the floor of the mouth.
METHODS: A total of 111 patients with SCC of the tongue and the floor of the mouth who received treatment between 2012 and 2017 were included in this study. The patients with lingual lymph nodes that were confirmed to be metastasis on pathological examination were classified into the LNN group. The demographic and clinical data differences between the No-LLN group and the LLN group were compared. Statistical analyses were performed using the Pearson chi-square test
RESULTS: The total incidence of LLNs was 17.12% (19/111) and 5 patients (4.5%) demonstrated LLN metastases. All the patients with LLN metastases had a neck lymph node status of N2 classification. The incidence and metastasis of the LLNs were associated with pathological classifications of SCC of the tongue and the floor of the mouth.
CONCLUSIONS: LLNs are rare in patients with SCC of the tongue and the floor of the mouth, and they would be ready to be omitted. The dissection of these LLNs would be of benefit to those patients with advanced pathological grade.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  floor of the mouth cancer; lingual lymph node; lymphatic metastasis; neck dissection; tongue cancer

Mesh:

Year:  2018        PMID: 30051610     DOI: 10.1002/hed.25340

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  [Influence of mandibulotomy approaches on oral function following radical resection of tongue carcinoma].

Authors:  Jian-Jun Wu; Xing Gao; Wen-Jin Wang; Gomaa Aly; Jie Chen; Ya-Qin Hu; Xin-Chun Jian; Can-Hua Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-06-01

2.  Regional metastasis to anatomies beyond traditional neck dissection boundaries: a multi-institutional analysis focused on unconventional metastases in oral cancer patients.

Authors:  Weijin Gao; Zhuowei Tian; Xiaodan Fang; Jincai Xue; Zhixiang Li; Cong Yang; Chunyue Ma
Journal:  World J Surg Oncol       Date:  2020-10-28       Impact factor: 2.754

3.  MR lymphography with superparamagnetic iron oxide for sentinel lymph node mapping of N0 early oral cancer: A pilot study.

Authors:  Satomi Sugiyama; Toshinori Iwai; Junichi Baba; Senri Oguri; Toshiharu Izumi; Masaki Sekino; Moriaki Kusakabe; Kenji Mitsudo
Journal:  Dentomaxillofac Radiol       Date:  2020-11-17       Impact factor: 2.419

4.  Lingual Lymph Node Metastasis in cT1-2N0 Tongue Squamous Cell Carcinoma: Is It an Indicator for Elective Neck Dissection.

Authors:  Wenli Yang; Minglei Sun; Qiaoyan Jie; Haixia Zhou; Peng Zhang; Juanfang Zhu
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

5.  Prognostic impact of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue: a retrospective study.

Authors:  Takeshi Kuroshima; Yusuke Onozato; Yu Oikawa; Toshimitsu Ohsako; Takuma Kugimoto; Hideaki Hirai; Hirofumi Tomioka; Yasuyuki Michi; Masahiko Miura; Ryoichi Yoshimura; Hiroyuki Harada
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

6.  Application of near-infrared fluorescence imaging in lingual lymph node screening and drainage pattern observation for tongue cancer.

Authors:  Yaoping Zhu; Tao Xiao; Yijia He; Xiaowei Hong; Ting Zhou; Mingjie Da; Sumeng Ge; Diya Xie; Zhiyong Wang
Journal:  Front Cell Dev Biol       Date:  2022-09-27

7.  CT lymphography for sentinel lymph node mapping of clinically N0 early oral cancer.

Authors:  Satomi Sugiyama; Toshinori Iwai; Toshiharu Izumi; Keita Ishiguro; Junichi Baba; Senri Oguri; Kenji Mitsudo
Journal:  Cancer Imaging       Date:  2019-11-12       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.